U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07383311) titled 'Autophagy-Enhancers to Reduce Sleep Disturbances' on Sept. 17, 2025.
Brief Summary: This clinical trial investigates the effects of spermidine supplementation on sleep quality and memory function in older adults with Mild Cognitive Impairment (MCI), a condition associated with an increased risk of developing dementia, particularly in patients with MCI due to Alzheimer's disease. Impaired sleep has been identified as a modifiable factor contributing to cognitive decline, and interventions targeting sleep architecture could offer therapeutic potential to prevent or slow down this decline.
Spermidine is a naturally occurring polyamine ...